[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb (BMY) Stock Moves 2.18%: What You Should Know",
    "summary": "Bristol Myers Squibb (BMY) closed at $44.54 in the latest trading session, marking a +2.18% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=44d76e82f9a535b3af02268599f919aafc9ea206e582d8be6fbf6a412c5839cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761083102,
      "headline": "Bristol Myers Squibb (BMY) Stock Moves 2.18%: What You Should Know",
      "id": 137188445,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers Squibb (BMY) closed at $44.54 in the latest trading session, marking a +2.18% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=44d76e82f9a535b3af02268599f919aafc9ea206e582d8be6fbf6a412c5839cd"
    }
  },
  {
    "ts": null,
    "headline": "Rates Going Lower Next Week: Our Top 5% Dividend Picks Could Soar",
    "summary": "These five top dividend stock picks are waiting for growth and income investors to step up to the plate. Plus, they are rated Buy at top firms on Wall Street",
    "url": "https://finnhub.io/api/news?id=6af624eaca5ae0c81e4e52321053836d281b2ca7517de9f4a4bec6df2c79377a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761054228,
      "headline": "Rates Going Lower Next Week: Our Top 5% Dividend Picks Could Soar",
      "id": 137178180,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "These five top dividend stock picks are waiting for growth and income investors to step up to the plate. Plus, they are rated Buy at top firms on Wall Street",
      "url": "https://finnhub.io/api/news?id=6af624eaca5ae0c81e4e52321053836d281b2ca7517de9f4a4bec6df2c79377a"
    }
  },
  {
    "ts": null,
    "headline": "Will BMY's Growth Portfolio Drive Third-Quarter Results?",
    "summary": "Bristol Myers leans on new drugs like Opdivo and Reblozyl to offset pressure from generics as its Growth Portfolio drives stability.",
    "url": "https://finnhub.io/api/news?id=413d9b2081ab4cb54c5c4624de3ca641162dae59775f9933fd67df893d491a31",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761051480,
      "headline": "Will BMY's Growth Portfolio Drive Third-Quarter Results?",
      "id": 137178115,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers leans on new drugs like Opdivo and Reblozyl to offset pressure from generics as its Growth Portfolio drives stability.",
      "url": "https://finnhub.io/api/news?id=413d9b2081ab4cb54c5c4624de3ca641162dae59775f9933fd67df893d491a31"
    }
  },
  {
    "ts": null,
    "headline": "The Play On Bristol-Myers Squibb",
    "summary": "The Play On Bristol-Myers Squibb",
    "url": "https://finnhub.io/api/news?id=e3b929cf488253a42fcf0278402ac90a1ec1fac6479996b4de42ff5f04886ce6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761046024,
      "headline": "The Play On Bristol-Myers Squibb",
      "id": 137178963,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e3b929cf488253a42fcf0278402ac90a1ec1fac6479996b4de42ff5f04886ce6"
    }
  }
]